The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Human Fatal Zaire Ebola Virus Infection Is Associated with an Aberrant Innate Immunity and with Massive Lymphocyte Apoptosis
Open accessAbstract
BACKGROUND: Ebolavirus species Zaire (ZEBOV) causes highly lethal hemorrhagic fever, resulting in the death of 90% of patients within days. Most information on immune responses to ZEBOV comes from in vitro studies and animal models. The paucity of data on human immune responses to this virus is mainly due to the fact that most outbreaks occur in remote areas. Published studies in this setting, based on small numbers of samples and limited panels of immunological markers, have given somewhat different results. METHODOLOGY/PRINCIPAL FINDINGS: Here, we studied a unique collection of 56 blood samples from 42 nonsurvivors and 14 survivors, obtained during the five outbreaks that occurred between 1996 and 2003 in Gabon and Republic of Congo. Using Luminex technology, we assayed 50 cytokines in all 56 samples and performed phenotypic analyses by flow cytometry. We found that fatal outcome was associated with hypersecretion of numerous proinflammatory cytokines (IL-1β, IL-1RA, IL-6, IL-8, IL-15 and IL-16), chemokines and growth factors (MIP-1α, MIP-1β, MCP-1, M-CSF, MIF, IP-10, GRO-α and eotaxin). Interestingly, no increase of IFNα2 was detected in patients. Furthermore, nonsurvivors were also characterized by very low levels of circulating cytokines produced by T lymphocytes (IL-2, IL-3, IL-4, IL-5, IL-9, IL-13) and by a significant drop of CD3+CD4+ and CD3+CD8+ peripheral cells as well as a high increase in CD95 expression on T lymphocytes. CONCLUSIONS/SIGNIFICANCE: This work, the largest study to be conducted to date in humans, showed that fatal outcome is associated with aberrant innate immune responses and with global suppression of adaptive immunity. The innate immune reaction was characterized by a "cytokine storm," with hypersecretion of numerous proinflammatory cytokines, chemokines and growth factors, and by the noteworthy absence of antiviral IFNα2. Immunosuppression was characterized by very low levels of circulating cytokines produced by T lymphocytes and by massive loss of peripheral CD4 and CD8 lymphocytes, probably through Fas/FasL-mediated apoptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Feldmann, H., & Geisbert, T. W. (2011) · The Lancet · doi:10.1016/s0140-6736(10)60667-8 · Cited by 1,374
Virus Taxonomy: VIIIth Report of the International Committee on Taxonomy of Viruses.
Fauquet, C., Mayo, M. A., Maniloff, J., Desselberger, U., & Ball, L. A. (2005) · Cited by 798
Multiple Ebola Virus Transmission Events and Rapid Decline of Central African Wildlife
Leroy, E. M., Rouquet, P., Formenty, P., Souquière, S., Kilbourne, A., Froment, J.-M., Bermejo, M., Smit, S., Karesh, W., Swanepoel, R., et al. (2004) · Science · doi:10.1126/science.1092528 · Cited by 794
Self-citationNewly Discovered Ebola Virus Associated with Hemorrhagic Fever Outbreak in Uganda
Towner, J. S., Sealy, T. K., Khristova, M. L., Albariño, C. G., Conlan, S., Reeder, S. A., Quan, P.-L., Lipkin, W. I., Downing, R., Tappero, J. W., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000212 · Cited by 599
Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques
Geisbert, T. W., Hensley, L. E., Larsen, T., Young, H. A., Reed, D. S., Geisbert, J. B., Scott, D. P., Kagan, E., Jahrling, P. B., & Davis, K. J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63591-2 · Cited by 576
Baize, S., Leroy, E. M., Georges-Courbot, M.-C., Capron, M., Lansoud-Soukate, J., Debré, P., Fisher-Hoch, S. P., McCormick, J. B., & Georges, A. J. (1999) · Nature Medicine · doi:10.1038/7422 · Cited by 551
Self-citationA Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever
Bray, M., Davis, K., Geisbert, T., Schmaljohn, C., & Huggins, J. (1998) · The Journal of Infectious Diseases · doi:10.1086/515386 · Cited by 492
The Ebola virus VP35 protein functions as a type I IFN antagonist
Basler, C. F., Wang, X., Mühlberger, E., Volchkov, V., Paragas, J., Klenk, H.-D., García-Sastre, A., & Palese, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220398297 · Cited by 478
The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3
Basler, C. F., Mikulasova, A., Martinez-Sobrido, L., Paragas, J., Mühlberger, E., Bray, M., Klenk, H.-D., Palese, P., & García-Sastre, A. (2003) · Journal of Virology · doi:10.1128/jvi.77.14.7945-7956.2003 · Cited by 477
Ebola haemorrhagic fever in Zaire
Otatume, S. (1996) · Journal of African Studies · doi:10.11619/africa1964.1996.49_95 · Cited by 474
Ebola Virus VP24 Binds Karyopherin α1 and Blocks STAT1 Nuclear Accumulation
Reid, S. P., Leung, L. W., Hartman, A. L., Martinez, O., Shaw, M. L., Carbonnelle, C., Volchkov, V. E., Nichol, S. T., & Basler, C. F. (2006) · Journal of Virology · doi:10.1128/jvi.02349-05 · Cited by 463
The Reemergence of Ebola Hemorrhagic Fever, Democratic Republic of the Congo, 1995
Khan, A. S., Tshioko, F. K., Heymann, D. L., Le Guenno, B., Nabeth, P., Kerstiëns, B., Fleerackers, Y., Kilmarx, P. H., Rodier, G. R., Nkuku, O., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514306 · Cited by 463
Cárdenas, W. B., Loo, Y.-M., Gale, M., Hartman, A. L., Kimberlin, C. R., Martínez-Sobrido, L., Saphire, E. O., & Basler, C. F. (2006) · Journal of Virology · doi:10.1128/jvi.02199-05 · Cited by 453
Human asymptomatic Ebola infection and strong inflammatory response
Leroy, E., Baize, S., Volchkov, V., Fisher-Hoch, S., Georges-Courbot, M.-C., Lansoud-Soukate, J., Capron, M., Debré, P., Georges, A., & McCormick, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02405-3 · Cited by 411
Self-citationPreliminary report: isolation of Ebola virus from monkeys imported to USA
Jahrling, P. B., Geisbert, T. W., Johnson, E. D., Peters, C. J., Dalgard, D. W., & Hall, W. C. (1990) · The Lancet · doi:10.1016/0140-6736(90)90737-p · Cited by 403
Isolation and partial characterisation of a new strain of Ebola virus
Le Guenno, B., Formenty, P., Wyers, M., Gounon, P., Walker, F., & Boesch, C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90925-7 · Cited by 402
Discovery of Swine as a Host for the Reston ebolavirus
Barrette, R. W., Metwally, S. A., Rowland, J. M., Xu, L., Zaki, S. R., Nichol, S. T., Rollin, P. E., Towner, J. S., Shieh, W.-J., Batten, B., et al. (2009) · Science · doi:10.1126/science.1172705 · Cited by 398
Geisbert, T. W., Young, H. A., Jahrling, P. B., Davis, K. J., Kagan, E., & Hensley, L. E. (2003) · The Journal of Infectious Diseases · doi:10.1086/379724 · Cited by 372
Inflammatory responses in Ebola virus-infected patients
BAIZE, S., LEROY, E. M., GEORGES, A. J., GEORGES-COURBOT, M.-C., CAPRON, M., BEDJABAGA, I., LANSOUD-SOUKATE, J., & MAVOUNGOU, E. (2002) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2002.01800.x · Cited by 370
Self-citationCutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses
Mahanty, S., Hutchinson, K., Agarwal, S., Mcrae, M., Rollin, P. E., & Pulendran, B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.2797 · Cited by 354
Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread.
Baron, R. C., McCormick, J. B., & Zubeir, O. A. (1983) · Europe PMC (PubMed Central) · Cited by 345
Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team.
(1978) · Europe PMC (PubMed Central) · Cited by 325
Pathogenesis of Ebola Hemorrhagic Fever in Primate Models
Geisbert, T. W., Young, H. A., Jahrling, P. B., Davis, K. J., Larsen, T., Kagan, E., & Hensley, L. E. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63592-4 · Cited by 318
The Ebola Virus VP35 Protein Is a Suppressor of RNA Silencing
Haasnoot, J., de Vries, W., Geutjes, E.-J., Prins, M., de Haan, P., & Berkhout, B. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030086 · Cited by 317
Pathogenesis of Experimental Ebola Virus Infection in Guinea Pigs
Connolly, B. M., Steele, K. E., Davis, K. J., Geisbert, T. W., Kell, W. M., Jaax, N. K., & Jahrling, P. B. (1999) · The Journal of Infectious Diseases · doi:10.1086/514305 · Cited by 308
Villinger, F., Rollin, P. E., Brar, S. S., Chikkala, N. F., Winter, J., Sundstrom, J. B., Zaki, S. R., Swanepoel, R., Ansari, A. A., & Peters, C. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/514283 · Cited by 307
Apoptosis Induced In Vitro and In Vivo During Infection by Ebola and Marburg Viruses
Geisbert, T. W., Hensley, L. E., Gibb, T. R., Steele, K. E., Jaax, N. K., & Jahrling, P. B. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780021 · Cited by 302
An outbreak of Ebola in Uganda
Okware, S. I., Omaswa, F. G., Zaramba, S., Opio, A., Lutwama, J. J., Kamugisha, J., Rwaguma, E. B., Kagwa, P., & Lamunu, M. (2002) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2002.00944.x · Cited by 300
Ebola Hemorrhagic Fever Outbreaks in Gabon, 1994–1997: Epidemiologic and Health Control Issues
Georges, A., Leroy, E. M., Renaut, A. A., Benissan, C. T., Nabias, R. J., Ngoc, M. T., Obiang, P. I., Lepage, J. P. M., Bertherat, E. J., Bénoni, D. D., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514290 · Cited by 298
Self-citationBosio, C. M., Aman, M. J., Grogan, C., Hogan, R., Ruthel, G., Negley, D., Mohamadzadeh, M., Bavari, S., & Schmaljohn, A. (2003) · The Journal of Infectious Diseases · doi:10.1086/379199 · Cited by 296
Human Infection Due to Ebola Virus, Subtype Côte d'Ivoire: Clinical and Biologic Presentation
Formenty, P., Hatz, C., Le Guenno, B., Stoll, A., Rogenmoser, P., & Widmer, A. (1999) · The Journal of Infectious Diseases · doi:10.1086/514285 · Cited by 283
Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages
Feldmann, H., Bugany, H., Mahner, F., Klenk, H. D., Drenckhahn, D., & Schnittler, H. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2208-2214.1996 · Cited by 256
Filoviridae: Marburg and Ebola viruses.
Hazar, S., & Akan, E. (2000) · Cited by 253
Evaluation in Nonhuman Primates of Vaccines against Ebola Virus
Geisbert, T. W., Pushko, P., Anderson, K., Smith, J., Davis, K. J., & Jahrling, P. B. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0805.010284 · Cited by 248
Reid, S. P., Valmas, C., Martinez, O., Sanchez, F. M., & Basler, C. F. (2007) · Journal of Virology · doi:10.1128/jvi.01097-07 · Cited by 248
Hensley, L. (2002) · Immunology Letters · doi:10.1016/s0165-2478(01)00327-3 · Cited by 242
Prins, K. C., Cárdenas, W. B., & Basler, C. F. (2009) · Journal of Virology · doi:10.1128/jvi.01875-08 · Cited by 241
[The epidemic of Ebola haemorrhagic fever in Sudan and Zaire, 1976: introductory note].
Brès, P. (1978) · Europe PMC (PubMed Central) · Cited by 225
Chang, T.-H., Kubota, T., Matsuoka, M., Jones, S., Bradfute, S. B., Bray, M., & Ozato, K. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000493 · Cited by 220
Gupta, M., Mahanty, S., Ahmed, R., & Rollin, P. E. (2001) · Virology · doi:10.1006/viro.2001.0836 · Cited by 192
Ebola virus: unravelling pathogenesis to combat a deadly disease
Hoenen, T., Groseth, A., Falzarano, D., & Feldmann, H. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.03.006 · Cited by 177
Kash, J. C., Mühlberger, E., Carter, V., Grosch, M., Perwitasari, O., Proll, S. C., Thomas, M. J., Weber, F., Klenk, H.-D., & Katze, M. G. (2006) · Journal of Virology · doi:10.1128/jvi.80.6.3009-3020.2006 · Cited by 175
Feng, Z., Cerveny, M., Yan, Z., & He, B. (2007) · Journal of Virology · doi:10.1128/jvi.01006-06 · Cited by 174
Evasion of Interferon Responses by Ebola and Marburg Viruses
Basler, C. F., & Amarasinghe, G. K. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2009.0076 · Cited by 171
Inhibition of IRF-3 Activation by VP35 Is Critical for the High Level of Virulence of Ebola Virus
Hartman, A. L., Bird, B. H., Towner, J. S., Antoniadou, Z.-A., Zaki, S. R., & Nichol, S. T. (2008) · Journal of Virology · doi:10.1128/jvi.02344-07 · Cited by 165
Becquart, P., Wauquier, N., Mahlakõiv, T., Nkoghe, D., Padilla, C. M., Souris, M., Ollomo, B., Gonzalez, J., de Lamballerie, X. N., Kazanji, M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009126 · Cited by 162
Self-citationStructure of the Ebola VP35 interferon inhibitory domain
Leung, D. W., Ginder, N. D., Fulton, D. B., Nix, J. C., Basler, C. F., Honzatko, R. B., & Amarasinghe, G. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807854106 · Cited by 161
Early immune responses accompanying human asymptomatic Ebola infections
Leroy, E. M., Baize, S., Debré, P., Lansoud-Soukate, J., & Mavoungou, E. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01517.x · Cited by 157
Self-citationReed, D. S., Hensley, L. E., Geisbert, J. B., Jahrling, P. B., & Geisbertl, T. W. (2004) · Viral Immunology · doi:10.1089/vim.2004.17.390 · Cited by 157
Bray, M., Hatfill, S. J., Hensley, L. E., & Huggins, J. W. (2001) · Journal of Comparative Pathology · doi:10.1053/jcpa.2001.0503 · Cited by 156
A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever
Bray, M., Davis, K., Geisbert, T., Schmaljohn, C. S., & Huggins, J. W. (1999) · The Journal of Infectious Diseases · doi:10.1086/514292 · Cited by 153
Rollin, P. E., Williams, R. J., Bressler, D. S., Pearson, S., Cottingham, M., Pucak, G. J., Sanchez, A., Trappier, S. G., Peters, R. L., Greer, P. W., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514303 · Cited by 151
Formenty, P. B. H., Leroy, E. M., Epelboïn, A., Libama, F., Lenzi, M., Sudeck, H., Yaba, P., Allarangar, Y., Boumandouki, P., Nkounkou, V. B., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/503836 · Cited by 149
Self-citationRole of Natural Killer Cells in Innate Protection against Lethal Ebola Virus Infection
Warfield, K. L., Perkins, J. G., Swenson, D. L., Deal, E. M., Bosio, C. M., Aman, M. J., Yokoyama, W. M., Young, H. A., & Bavari, S. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032141 · Cited by 148
Hartman, A. L., Towner, J. S., & Nichol, S. T. (2004) · Virology · doi:10.1016/j.virol.2004.07.006 · Cited by 145
Pathogenesis of Experimental Ebola Zaire Virus Infection in BALB/c Mice
Gibb, T. R., Bray, M., Geisbert, T. W., Steele, K. E., Kell, W. M., Davis, K. J., & Jaax, N. K. (2001) · Journal of Comparative Pathology · doi:10.1053/jcpa.2001.0502 · Cited by 144
Isolates of Zaire ebolavirus from wild apes reveal genetic lineage and recombinants
Wittmann, T., Biek, R., Hassanin, A., Rouquet, P., Reed, P. E., Yaba, P., Pourrut, X., Real, L. A., Gonzalez, J., & Leroy, E. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704076104 · Cited by 135
Self-citationOutbreak of Ebola Hemorrhagic Fever—Uganda, August 2000-January 2001
(2001) · JAMA · doi:10.1001/jama.285.8.1010-jwr0228-2-1 · Cited by 131
Schnittler, H., Mahner, F., Drenckhahn, D., Klenk, H., & Feldmann, H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116329 · Cited by 123
Volchkov, V. E., Blinov, V. M., & Sv, N. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80662-z · Cited by 122
Ebola Hemorrhagic Fever and Septic Shock
Bray, M., & Mahanty, S. (2003) · The Journal of Infectious Diseases · doi:10.1086/379727 · Cited by 120
Harcourt, B. H., Sanchez, A., & Offermann, M. K. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3491-3496.1999 · Cited by 113
Hartman, A. L., Ling, L., Nichol, S. T., & Hibberd, M. L. (2008) · Journal of Virology · doi:10.1128/jvi.00215-08 · Cited by 106
Rubins, K., Hensley, L. E., Wahl‐Jensen, V., Daddario-DiCaprio, K. M., Young, H. A., Reed, D. S., Jahrling, P. B., Brown, P. O., Relman, D. A., & Geisbert, T. W. (2007) · Genome biology · doi:10.1186/gb-2007-8-8-r174 · Cited by 94
Yaddanapudi, K., Palacios, G. F., Towner, J. S., Chen, I., Sariol, C. A., Nichol, S. T., & Lipkin, W. I. (2006) · The FASEB Journal · doi:10.1096/fj.06-6151com · Cited by 78
Ebola haemorrhagic fever in Zaire, 1995
Clegg, J. C. S., & Lloyd, G. (1995) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-199508000-00001 · Cited by 77
Apoptosis in fatal Ebola infection. Does the virus toll the bell for immune system?
Baize, S., Leroy, E. M., Mavoungou, E., & Fisher‐Hoch, S. P. (2000) · APOPTOSIS · doi:10.1023/a:1009657006550 · Cited by 72
Self-citation
Cited by
Iba, T., Levy, J. H., Levi, M., & Thachil, J. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14975 · Cited by 585
The Pathogenesis of Ebola Virus Disease
Baseler, L., Chertow, D. S., Johnson, K. M., Feldmann, H., & Morens, D. M. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100506 · Cited by 404
Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses
Martines, R. B., Ng, D. L., Greer, P. W., Rollin, P. E., & Zaki, S. R. (2015) · The Journal of Pathology · doi:10.1002/path.4456 · Cited by 319
Pathogenesis of the Viral Hemorrhagic Fevers
Paessler, S., & Walker, D. H. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-164041 · Cited by 309
Human Ebola virus infection results in substantial immune activation
McElroy, A. K., Akondy, R. S., Davis, C. W., Ellebedy, A. H., Mehta, A. K., Kraft, C. S., Lyon, G. M., Ribner, B. S., Varkey, J., Sidney, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502619112 · Cited by 306
Metadata
- Authors
- Wauquier, N., Becquart, P., Padilla, C., Baize, S., & Leroy, E. M.
- Venue
- PLoS Neglected Tropical Diseases
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-10-05
- Volume
- 4
- Issue
- 10
- Pages
- e837
- ISSN
- 1935-2727 (ISSN-L)
- 1935-2735
- OpenAlex
- W1966742128
- Cited by
- 377
- References
- 67
- FWCI
- 9.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.